Cuts to research funding jeopardize ongoing studies and the education of future scientists, potentially leading to significant losses in data and biological samples essential for health research.
Corporate treasuries have surpassed exchange-traded funds (ETFs) in Bitcoin accumulation, with public companies acquiring approximately 131,000 BTC in Q2 2025, an 18% increase from the previous quarter.